An open label study to evaluate the effect of CellCept [mycophenolate mofetil] in combination wth cyclosporine A and steroids on renal function and the prevention of acute rejection in heart transplant patients
Phase of Trial: Phase III
Latest Information Update: 03 Dec 2014
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Ciclosporin; Corticosteroids
- Indications Heart transplant rejection
- Focus Therapeutic Use
- Sponsors Roche
- 17 Mar 2014 New source identified and integrated (ClinicalTrial.gov; NCT02091414)
- 19 Sep 2008 Status changed from active, no longer recruiting to completed, as reported by Roche.
- 10 Jan 2008 New trial record.